These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24932473)

  • 1. Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer.
    Goode G; Pratap S; Eltom SE
    PLoS One; 2014; 9(6):e100103. PubMed ID: 24932473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.
    Goode GD; Ballard BR; Manning HC; Freeman ML; Kang Y; Eltom SE
    Int J Cancer; 2013 Dec; 133(12):2769-80. PubMed ID: 23733406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.
    Hiyoshi H; Goto N; Tsuchiya M; Iida K; Nakajima Y; Hirata N; Kanda Y; Nagasawa K; Yanagisawa J
    Sci Rep; 2014 Nov; 4():7095. PubMed ID: 25403352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.
    Novikov O; Wang Z; Stanford EA; Parks AJ; Ramirez-Cardenas A; Landesman E; Laklouk I; Sarita-Reyes C; Gusenleitner D; Li A; Monti S; Manteiga S; Lee K; Sherr DH
    Mol Pharmacol; 2016 Nov; 90(5):674-688. PubMed ID: 27573671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
    Jin UH; Lee SO; Pfent C; Safe S
    BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AhR ligands reactivate LINE-1 retrotransposon in triple-negative breast cancer cells MDA-MB-231 and non-tumorigenic mammary epithelial cells NMuMG.
    Miret N; Zappia CD; Altamirano G; Pontillo C; Zárate L; Gómez A; Lasagna M; Cocca C; Kass L; Monczor F; Randi A
    Biochem Pharmacol; 2020 May; 175():113904. PubMed ID: 32156659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Expression Profiling Identifies Cell Proliferation and Inflammation as the Predominant Pathways Regulated by Aryl Hydrocarbon Receptor in Primary Human Fetal Lung Cells Exposed to Hyperoxia.
    Shivanna B; Maity S; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Belmont J; Coarfa C; Moorthy B
    Toxicol Sci; 2016 Jul; 152(1):155-68. PubMed ID: 27103661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
    Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
    PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.
    Mortensen AS; Arukwe A
    Chem Res Toxicol; 2007 Mar; 20(3):474-88. PubMed ID: 17291011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.
    Brooks J; Eltom SE
    Curr Cancer Drug Targets; 2011 Jun; 11(5):654-69. PubMed ID: 21486221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.
    Yamashita N; Kanno Y; Saito N; Terai K; Sanada N; Kizu R; Hiruta N; Park Y; Bujo H; Nemoto K
    Biochem Biophys Res Commun; 2019 Aug; 516(3):693-698. PubMed ID: 31253396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
    Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
    Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
    Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
    BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    Vacher S; Castagnet P; Chemlali W; Lallemand F; Meseure D; Pocard M; Bieche I; Perrot-Applanat M
    PLoS One; 2018; 13(1):e0190619. PubMed ID: 29320557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C; Hockla A; Miller E; Ran S; Radisky DC; Radisky ES
    Oncotarget; 2014 May; 5(9):2736-49. PubMed ID: 24811362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.